Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Alignment healthcare CIO sells shares worth over $8,800

Published 03/29/2024, 08:02 PM
ALHC
-

Robert L. Scavo, the Chief Information Officer of Alignment Healthcare, Inc. (NASDAQ:ALHC), recently sold shares of the company's common stock. The transaction, which took place on March 28, 2024, involved the sale of 1,821 shares at an average price of $4.84 per share, totaling approximately $8,813.

This sale was executed to cover tax withholding obligations related to the vesting of restricted stock units. It is important to note that this move was not a discretionary trade by Scavo but a mandatory action to fulfill tax requirements. The shares were sold in multiple transactions with prices ranging from $4.73 to $4.935.

Following this transaction, Scavo continues to hold a significant stake in the company, with 436,822 shares of Alignment Healthcare's common stock remaining in his possession.

Investors and stakeholders of Alignment Healthcare are often keen to monitor the trading activity of insiders as it can provide insights into their perspective on the company's current valuation and future prospects. However, it's crucial to consider that transactions like these are sometimes part of predetermined financial planning strategies and may not always signal changes in company performance or management's outlook.

The company, based in Orange, California, operates within the hospital and medical service plans industry and is incorporated in Delaware. Alignment Healthcare continues to focus on providing its services, as indicated by its business filings and public communications.

InvestingPro Insights

Alignment Healthcare, Inc. (NASDAQ:ALHC) has been navigating a challenging market environment, as reflected in recent trading activity and financial metrics. According to InvestingPro data, the company's market capitalization stands at $937.33 million, with a negative Price to Earnings (P/E) ratio of -6.25, suggesting that investors are anticipating future growth to justify the current stock valuation. The Price to Book (P/B) ratio as of the last twelve months ending Q4 2023 is 5.97, indicating that the stock is trading at a premium relative to the company's book value.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Tips highlight that Alignment Healthcare holds more cash than debt on its balance sheet, which could be a sign of financial stability. However, the company's stock has experienced a significant decline over the past three months, with a 42.39% drop in total return. These trends suggest that while the company may have a solid cash position, market sentiment has been bearish. Notably, analysts have revised their earnings expectations downwards for the upcoming period, and they do not anticipate the company will be profitable this year.

For investors looking for a more in-depth analysis, there are additional tips available on InvestingPro, which can be accessed at https://www.investing.com/pro/ALHC. These tips may provide further insights into Alignment Healthcare's performance and valuation. To enhance your InvestingPro experience, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. Currently, there are 9 additional InvestingPro Tips listed for ALHC that could further inform investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.